Open AccessChanging bacteriological profile and mortality trends in community acquired pneumonia
Author(s) -
Sagar Khadanga,
Tadepalli Karuna,
Pravat Kumar Thatoi,
Sarat Kumar Behera
Publication year - 2014
Publication title -
journal of global infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.437
H-Index - 25
eISSN - 0974-8245
pISSN - 0974-777X
DOI - 10.4103/0974-777x.145251
Subject(s) - streptococcus pneumoniae , klebsiella pneumoniae , pseudomonas aeruginosa , pneumonia , microbiology and biotechnology , community acquired pneumonia , piperacillin , medicine , staphylococcus aureus , population , biology , antibiotics , bacteria , environmental health , escherichia coli , biochemistry , genetics , gene
There are very few and conflicting Indian data regarding the bacteriological etiology of community acquired pneumonia (CAP). Adding to this agony, there is no credible data from the eastern part of India. This is a cross-sectional study and descriptive in nature over a period of 1-year. Of the 464 cases of the study population, we could isolate aerobic bacteria in 149 patients (32.1%). Streptococcus pneumoniae has been identified as the most common organism causing CAP (68/149). Gram-negative bacilli (GNB) as a group exceeded marginally over S. pneumoniae (69/149). Among GNB, Pseudomonas aeruginosa was the most common organism (31/69), followed by Klebsiella pneumoniae (29/69). Staphylococcus aureus was identified in (12/149) cases. Co-amoxyclav is still the most sensitive drug for S. pneumoniae. P. aeruginosa was most sensitive to imipenam followed by piperacillin-tazobactam.